SALARIUS PHARMACEUTICALS INC's ticker is SLRX and the CUSIP is 79400X107. A total of 26 filers reported holding SALARIUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 1,502 | +0.1% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -99.9% | 1,500 | -99.8% | 0.00% | – |
| Q3 2021 | $775,000 | +48.8% | 759,772 | +54.8% | 0.00% | – |
| Q2 2021 | $521,000 | +25950.0% | 490,802 | +30613.5% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 1,598 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 1,598 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -92.9% | 1,598 | -84.6% | 0.00% | – |
| Q2 2020 | $14,000 | +1300.0% | 10,400 | +550.8% | 0.00% | – |
| Q1 2020 | $1,000 | -83.3% | 1,598 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | -33.3% | 1,598 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | – | 1,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| X-Square Capital, LLC | 97,258 | $39,000 | 0.02% |
| Kepos Capital LP | 548,054 | $218,000 | 0.02% |
| Virtu Financial LLC | 39,476 | $16,000 | 0.00% |
| Laird Norton Wetherby Wealth Management, LLC | 39,746 | $16,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 16,400 | $7,000 | 0.00% |
| NORTHERN TRUST CORP | 65,022 | $26,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 390,115 | $155,000 | 0.00% |
| STATE STREET CORP | 142,552 | $57,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 20,128 | $8,000 | 0.00% |